Richard A. Spellman
Papers
1
Total Citations
74
H-Index
1
About
Richard A. Spellman is a leading figure in genetic toxicology and safety assessment, best known for pioneering high-content, multiplexed in vitro genotoxicity assays that integrate DNA damage and cell cycle biomarkers. His most cited work, the 2017 interlaboratory evaluation of a flow cytometry-based assay measuring p53, γH2AX, and phospho-histone H3, demonstrated remarkable reproducibility across multiple labs—a critical step toward regulatory acceptance. This assay, which simultaneously assesses clastogenicity, aneugenicity, and mitotic disruption from a single sample, has become a cornerstone of modern genotoxicity screening, cited over 70 times. Spellman’s contributions extend to developing the use of internal counting beads for absolute nuclei quantification, enhancing assay precision. His work bridges mechanistic toxicology and practical risk assessment, reducing reliance on traditional animal-based tests. By enabling high-throughput, multi-parametric analysis, Spellman has fundamentally advanced how researchers evaluate chemical safety, making his methods indispensable in pharmaceutical and environmental toxicology. His achievements reflect a career dedicated to transforming genotoxicity testing through innovation, collaboration, and rigorous validation.
Research Focus
Key Achievements
Top Papers
- 1